{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:23:04Z","timestamp":1760145784224,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.micpath.2021.105000","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T12:16:12Z","timestamp":1621944972000},"page":"105000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evaluation of the PBP2 transglycosylase region of Staphylococcus aureus as a target for immunotherapeutic approaches"],"prefix":"10.1016","volume":"157","author":[{"given":"Ana Paula","family":"Corr\u00eaa Argondizzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4873-5623","authenticated-orcid":false,"given":"Felipe Betoni","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Maria","family":"Nunes Peres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Proc\u00f3pio","family":"Moreno Senna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.105000_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2021.105000_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin. Infect. Dis."},{"year":"2017","series-title":"Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics","author":"Who","key":"10.1016\/j.micpath.2021.105000_bib3"},{"key":"10.1016\/j.micpath.2021.105000_bib4","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1128\/AAC.38.4.724","article-title":"Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus","volume":"38","author":"Ryffel","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.105000_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00203-002-0436-0","article-title":"Factors influencing methicillin resistance in staphylococci","volume":"178","author":"Berger-B\u00e4chi","year":"2002","journal-title":"Arch. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2021.105000_bib6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/MMBR.62.4.1079-1093.1998","article-title":"Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs","volume":"62","author":"Goffin","year":"1998","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.micpath.2021.105000_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1574-6976.2008.00105.x","article-title":"The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis","volume":"32","author":"Sauvage","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.micpath.2021.105000_bib8","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.1136611","article-title":"Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis","volume":"315","author":"Lovering","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.micpath.2021.105000_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1574-6976.2007.00089.x","article-title":"The biosynthesis of peptidoglycan lipid linked intermediates","volume":"32","author":"Bouhss","year":"2007","journal-title":"FEMS Microbiol"},{"key":"10.1016\/j.micpath.2021.105000_bib10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2174\/0929867003374651","article-title":"Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis","volume":"7","author":"Goldman","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.micpath.2021.105000_bib11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/jac\/44.6.767","article-title":"ADN vaccination by mecA sequence evokes an antibacterial immune response against methicillin-resistant Staphylococcus aureus","volume":"44","author":"Ohwada","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2021.105000_bib12","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/S0264-410X(02)00738-7","article-title":"Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approach","volume":"21","author":"Senna","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.105000_bib13","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1073\/pnas.122108599","article-title":"The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)","volume":"99","author":"Enright","year":"2002","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.micpath.2021.105000_bib14","doi-asserted-by":"crossref","unstructured":"K\u00e4ll L, Krogh A, Sonnhammer ELL. A combined transmembrane topology and signal peptide prediction method. J. Mol. Biol.,338:1027-1036.","DOI":"10.1016\/j.jmb.2004.03.016"},{"key":"10.1016\/j.micpath.2021.105000_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/protein\/10.1.1","article-title":"Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites","volume":"10","author":"Nielsen","year":"1997","journal-title":"Protein Eng."},{"key":"10.1016\/j.micpath.2021.105000_bib16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/bioinformatics\/14.4.378","article-title":"Classification and secondary structure prediction system for membrane proteins","volume":"14","author":"Hirokawa","year":"1998","journal-title":"Bioinformatics"},{"key":"10.1016\/j.micpath.2021.105000_bib17","first-page":"175","article-title":"A hidden Markov model for predicting transmembrane helices in protein sequences","volume":"6","author":"Sonnhammer","year":"1998","journal-title":"Proc. Int. Conf. Intell. Syst. Mol. Biol."},{"key":"10.1016\/j.micpath.2021.105000_bib18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/bioinformatics\/bti057","article-title":"PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis","volume":"21","author":"Gardy","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.micpath.2021.105000_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/9858","article-title":"Generation of tissue-specific and promiscuous HLA ligand database using DNA microarrays and virtual HLA class II matrices","volume":"17","author":"Sturniolo","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.micpath.2021.105000_bib20","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/bioinformatics\/17.12.1236","article-title":"ProPred: prediction of HLA-DR binding sites","volume":"17","author":"Singh","year":"2001","journal-title":"Bioinformatics"},{"key":"10.1016\/j.micpath.2021.105000_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/mab.2015.0013","article-title":"Generation and characterization of murine monoclonal antibodies anti-PBP2a of Methicillin-resistant Staphylococcus aureus","volume":"34","author":"Senna","year":"2015","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.micpath.2021.105000_bib22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1073\/pnas.80.3.697","article-title":"Gene for staphylococcal protein A","volume":"80","author":"Lofdhal","year":"1983","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.micpath.2021.105000_bib23","doi-asserted-by":"crossref","first-page":"9387","DOI":"10.1007\/s00253-020-10912-5","article-title":"Application of IgY antibodies against staphylococcal protein A (SpA) of Staphylococcus aureus for detection and prophylactic functions","volume":"104","author":"Kota","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2021.105000_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bioorg.2014.05.007","article-title":"Prospects for novel inhibitors of peptidoglycan transglycosylases","volume":"55","author":"Galley","year":"2014","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.micpath.2021.105000_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225752","article-title":"Monoclonal antibody anti-PBP2a protects mice against MRSA (methicillin-resistant Staphylococcus aureus) infections","author":"Saraiva","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.105000_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.intimp.2018.01.035","article-title":"Passive immunization against methicillin resistant Staphylococcus aureus recombinant PBP2a in sepsis model of mice: comparable results with antibiotic therapy","volume":"56","author":"Naghshbandi","year":"2018","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.micpath.2021.105000_bib27","doi-asserted-by":"crossref","first-page":"103945","DOI":"10.1016\/j.micpath.2019.103945","article-title":"Recombinant PBP2a of methicillin-resistant S. aureus formulation in Alum and Montanide ISA266 adjuvants induced cellular and humoral immune responses with protection in Balb\/C mice","volume":"140","author":"Mortazavi","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2021.105000_bib28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nrmicro.2017.104","article-title":"The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota","volume":"15","author":"Krismer","year":"2017","journal-title":"Nat. Rev. Microbiol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021002722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021002722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:45:59Z","timestamp":1760111159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401021002722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":28,"alternative-id":["S0882401021002722"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.105000","relation":{},"ISSN":["0882-4010"],"issn-type":[{"type":"print","value":"0882-4010"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the PBP2 transglycosylase region of Staphylococcus aureus as a target for immunotherapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.105000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105000"}}